Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease

OBJECTIVE: Microglia play a pivotal role in the initiation and progression of Alzheimer's disease (AD). We here tested the therapeutic hypothesis that the Ca(2+)‐activated potassium channel KCa3.1 constitutes a potential target for treating AD by reducing neuroinflammation. METHODS: To determin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Clin Transl Neurol
Egile Nagusiak: Jin, Lee‐Way, Lucente, Jacopo Di, Nguyen, Hai M., Singh, Vikrant, Singh, Latika, Chavez, Monique, Bushong, Trevor, Wulff, Heike, Maezawa, Izumi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2019
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6469250/
https://ncbi.nlm.nih.gov/pubmed/31019997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.754
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak